PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSupernus Pharmaceuticals
Supernus Pharmaceuticals(SUPN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OxtellarOxcarbazepine2012-10-192027
Epilepsy
,
Partial epilepsies
QelbreeViloxazine2021-04-022029-2033
Depression
TrokendiTopiramate2013-08-162027-2040
Pain
,
Epilepsy
,
Lennox gastaut syndrome
,
Infantile spasms
,
Partial epilepsies
,
Tonic-clonic epilepsy
,
Bipolar disorder
,
Obesity
GocovriAmantadine2017-08-242025-2038
Parkinson disease,
Secondary parkinson disease,
Human influenza,
Dystonia,
Drug-induced dyskinesia,
Drug-induced akathisia
OsmolexAmantadine2018-02-162025-2038
Parkinson disease,
Secondary parkinson disease,
Human influenza,
Dystonia,
Drug-induced dyskinesia,
Drug-induced akathisia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Topiramate
epilepsy
,
migraine disorders
,
headache
Oxcarbazepine
epilepsy
,
partial epilepsies
,
seizures
Viloxazine
attention deficit disorder with hyperactivity
,
hyperkinesis
Benzocaine
seizures
Ademetionine
epilepsy
Glutamic acid
hyperkinesis
,
attention deficit disorder with hyperactivity
,
aggression
,
impulsive behavior
Aspartame
epilepsy
D-glutamate
hyperkinesis
,
attention deficit disorder with hyperactivity
,
aggression
,
impulsive behavior
Ipx066
parkinson disease
Azzalure
muscle spasticity
,
sialorrhea
,
stroke
,
wounds and injuries
,
multiple sclerosis
,
traumatic brain injuries
,
spinal cord injuries
,
brain injuries
,
cerebral palsy
,
sclerosis
Pbo
depression
,
treatment-resistant depressive disorder
,
depressive disorder
,
attention deficit disorder with hyperactivity
,
muscle spasticity
,
hyperkinesis
,
stroke
,
wounds and injuries
,
multiple sclerosis
,
traumatic brain injuries
,
spinal cord injuries
,
brain injuries
,
cerebral palsy
,
sclerosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use